Autoren

David Mulder

Senior Associate

Read More

Christian Dekoninck

Partner

Read More

Adrian Toutoungi

Partner

Read More

Dr. Anja Lunze, LL.M.

Partner

Read More

Dr. Angela Knierim

Salary Partner

Read More
Autoren

David Mulder

Senior Associate

Read More

Christian Dekoninck

Partner

Read More

Adrian Toutoungi

Partner

Read More

Dr. Anja Lunze, LL.M.

Partner

Read More

Dr. Angela Knierim

Salary Partner

Read More

23. November 2020

Pharmaceutical patent law – 2 von 2 Insights

Pharmaceutical patent law in times of crisis: A comparative study – Part 2

  • Quick read

Which extraordinary regulations have been put in place for speeding up clinical trials in emergency situations like the current coronavirus pandemic? And how is early access to new medicines warranted under such circumstance?

The second part of the two-part series ‘Pharmaceutical Patent Law in Times of Crisis: A Comparative Study’, written for the European Intellectual Property Review by our international team, addresses these questions and more on both a broad, European level and from the perspective of six national jurisdictions.
 

Read the article here

In dieser Serie

Patents Technology & Life Sciences

Pharmaceutical patent law in times of crisis: A comparative study – Part 1

9. November 2020

von mehreren Autoren

Patents Technology & Life Sciences

Pharmaceutical patent law in times of crisis: A comparative study – Part 2

23. November 2020

von mehreren Autoren

Call To Action Arrow Image

Newsletter-Anmeldung

Wählen Sie aus unserem Angebot Ihre Interessen aus!

Jetzt abonnieren
Jetzt abonnieren

Related Insights

UPC

It is time to think about UPC opt-out again: how it is achieved and its strategic implications

Part 2

17. Januar 2022
In-depth analysis

von mehreren Autoren

Klicken Sie hier für Details
UPC

It is time to think about UPC opt-out again: what opt-out does

Part 1

17. Januar 2022
In-depth analysis

von mehreren Autoren

Klicken Sie hier für Details
Patents Technology & Life Sciences

Taylor Wessing announces a major Unified Patent Court publishing project

22. November 2021
Quick read

von mehreren Autoren

Klicken Sie hier für Details